|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.9 TWD | -0.52% |
|
+2.30% | -26.37% |
Golden Biotechnology Corporation reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 28.89 million compared to TWD 60.93 million a year ago. Net loss was TWD 143.12 million compared to TWD 207.76 million a year ago.
Basic loss per share from continuing operations was TWD 1.01 compared to TWD 1.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.37% | 126M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
GOLDEN BIOTECHNOLOGY CORPORATION 
